A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Rain by Monday afternoon. Warm yet humid on Tuesday. Kerrie has the detail.....
Mainly dry for Sunday. Rain risk into Monday and later on Tuesday
12 Clipper Round the World 70ft yachts begin their full circumnavigation from Liverpool today